FrancophonIA/ELRC3.0 huggingface dataset:
English: In combination studies of emtricitabine with NRTIs (abacavir, didanosine, lamivudine, stavudine, tenofovir, and zidovudine), NNRTIs (delavirdine, efavirenz, nevirapine, and rilpivirine), and PIs (amprenavir, nelfinavir, ritonavir, and saquinavir), additive to synergistic effects were observed.
Danish: I kombinationsstudier af emtricitabin sammen med NRTI'er (abacavir, didanosin, lamivudin, stavudin, tenofovir og zidovudin), NNRTI'er (delavirdin, efavirenz, nevirapin og rilpivirin) og PI'er (amprenavir, nelfinavir, ritonavir og saquinavir), blev der observeret additive til synergistiske virkninger.
English: • Tiredness or drowsiness
Danish: • Træthed eller døsighed
English: Tenofovir pharmacokinetics was not substantially altered in subjects with hepatic impairment suggesting that no dose adjustment is required in these subjects.
Danish: Der skete ingen betydelig ændring i tenofovirs farmakokinetik hos probander med nedsat leverfunktion, hvilket tyder på, at det ikke er nødvendigt at justere dosis hos disse personer.
English: If Eviplera is co-administered with rifabutin, an additional 25 mg tablet of rilpivirine per day is recommended to be taken concomitantly with Eviplera, for the duration of the rifabutin coadministration (see section 4.5).
Danish: Hvis Eviplera indgives samtidig med rifabutin, anbefales det at tage yderligere én rilpivirin-tablet på 25 mg dagligt samtidig med Eviplera, så længe den samtidige administration af rifabutin varer (se pkt.
English: Patients were randomised in a 1:1 ratio to receive either rilpivirine hydrochloride 25 mg (n = 686) once daily or efavirenz 600 mg (n = 682) once daily in addition to a BR.
Danish: Patienterne blev randomiseret i et forhold på 1:1 til at få enten rilpivirinhydrochlorid 25 mg (n = 686) én gang dagligt eller efavirenz 600 mg (n = 682) én gang dagligt i tillæg til BR. I studie C209 (n = 690) var BR emtricitabin/tenofovirdisoproxil.
English: No dose adjustment is recommended.
Danish: Anbefaling for dosisjustering foreligger ikke.
English: hypertriglyceridaemia1, 2, hyperglycaemia1, decreased appetite2
Danish: hypertriglyceridæmi1, 2, hyperglykæmi1, nedsat appetit2 Ikke almindelig: hypokaliæmi3, 5
English: Recommendation concerning co-administration with Eviplera
Danish: samtidig administration af Eviplera
English: There is insufficient information on the effects of Eviplera in newborns/infants.
Danish: Der foreligger utilstrækkelige data for virkningen af Eviplera på det ammede barn.
English: Sunset yellow aluminium lake (E110) Titanium dioxide
Danish: Sunset yellow FCF aluminium lak (E110) Titandioxid
English: Limited data from clinical studies support once daily dosing of Eviplera in patients with mild renal impairment (CrCl 50-80 mL/min).
Danish: Begrænsede data fra kliniske studier støtter en dosering af Eviplera én gang dagligt hos patienter med let nedsat nyrefunktion (CrCl 50-80 ml/min).
English: In the pooled efficacy analysis from the two Phase III clinical studies (C209 [ECHO] and C215 [THRIVE]) through 96 weeks, patients treated with emtricitabine/tenofovir disoproxil + rilpivirine with a baseline viral load > 100,000 HIV-1 RNA copies/mL had a greater risk of virologic failure (17.6% with rilpivirine versus 7.6% with efavirenz) compared to patients with a baseline viral load ≤ 100,000 HIV-1 RNA copies/mL (5.9% with rilpivirine versus 2.4% with efavirenz).
Danish: I den samlede effektanalyse af de to kliniske fase III-studier (C209 [ECHO] og C215 [THRIVE]) til og med uge 96 havde patienter i behandling med emtricitabin/tenofovirdisoproxil + rilpivirin med en virusbelastning ved baseline på > 100.000 hiv 1-rna-kopier/ml en større risiko for virologisk svigt (17,6 % med rilpivirin versus 7,6 % med efavirenz) sammenlignet med patienter med en virusbelastning ved baseline på ≤ 100.000 hiv 1-rna-kopier/ml (5,9 % med rilpivirin versus 2,4 % med efavirenz).
English: If a patient misses a dose of Eviplera by more than 12 hours, the patient should not take the missed dose and simply resume the usual dosing schedule.
Danish: Hvis en patient glemmer at tage en dosis Eviplera i mere end 12 timer, skal patienten ikke tage den manglende dosis, men blot fortsætte med den normale doseringsplan.
English: • proton pump inhibitors, such as omeprazole, esomeprazole, lansoprazole, pantoprazole,
Danish: • protonpumpehæmmere, såsom omeprazol, esomeprazol, lansoprazol, pantoprazol, rabeprazol
English: vesiculobullous rash1, pustular rash1, urticaria1, skin discolouration (increased pigmentation)1, 4, maculopapular rash1, pruritus1
Danish: vesikulobulløst udslæt1, pustuløst udslæt1, urticaria1, misfarvning af huden (øget pigmentering)1, 4, makulopapuløst udslæt1, pruritus1
English: Rifampicin/Emtricitabine
Danish: Rifampicin/Emtricitabin
English: Resistance outcomes, including cross-resistance to other NNRTIs, in patients receiving rilpivirine hydrochloride in combination with emtricitabine/tenofovir disoproxil in Phase III studies (C209 and C215 pooled data) and experiencing virological failure, are shown in Table 3 below.
Danish: Data for resistens, herunder krydsresistens, over for andre NNRTI'er hos patienter, der fik rilpivirinhydrochlorid i kombination med emtricitabin/tenofovirdisoproxil i fase III-studier (samlede data fra C209 og C215), og som oplevede virologisk svigt, er vist i Tabel 3 nedenfor.
English: • Decrease in haemoglobin in your blood (low red blood cell count)
Danish: • Mindre hæmoglobin i blodet (et lavt antal røde blodlegemer)
English: Eviplera should be used with caution when co-administered with medicinal products with a known risk of Torsade de Pointes.
Danish: Eviplera bør anvendes med forsigtighed ved samtidig administration af lægemidler med en kendt risiko for torsades de pointes.
English: Limited data from clinical studies support once daily dosing of Eviplera in patients with mild renal impairment (creatinine clearance (CrCl) 50-80 mL/min).
Danish: Begrænsede data fra kliniske studier støtter en dosering af Eviplera én gang dagligt hos patienter med let nedsat nyrefunktion (kreatininclearance (CrCl) 50-80 ml/min).
English: If a patient vomits more than 4 hours after taking Eviplera they do not need to take another dose of Eviplera until the next regularly scheduled dose.
Danish: Hvis en patient kaster op mere end 4 timer efter at have taget Eviplera, skal patienten ikke tage en ny dosis af Eviplera, indtil den næste regelmæssigt skemalagte dosis.
English: Eviplera should not be administered concomitantly with adefovir dipivoxil.
Danish: Eviplera bør ikke indgives samtidig med adefovirdipivoxil.
English: • Increased levels of liver enzymes in the blood
Danish: • Forhøjede leverenzym-niveauer i blodet
English: The median change in CD4+ cell count at week 48 was +17 x 106 cells/L, in the on-treatment analysis.
Danish: Den mediane ændring i CD4-celletallet i analysen af patienter i behandling ved uge 48 var +17 x 106 celler/l.
English: The adverse reaction profile of emtricitabine, rilpivirine hydrochloride and tenofovir disoproxil in patients co-infected with HIV/HBV or HIV/HCV was similar to that observed in patients infected with HIV without co-infection.
Danish: Patienter, som både er inficerede med hiv og HBV eller HCV Bivirkningsprofilen af emtricitabin, rilpivirinhydrochlorid og tenofovirdisoproxil hos patienter, som samtidigt er inficerede med hiv/HBV eller hiv/HCV lignede den, der observeres hos patienter, som kun er inficerede med hiv.
English: Integrase strand transfer inhibitors Raltegravir/Emtricitabine
Danish: Integrase strengoverførsels-hæmmere Raltegravir/Emtricitabin
English: The bioequivalence of one Eviplera film-coated tablet with one emtricitabine 200 mg hard capsule, one rilpivirine (as hydrochloride) 25 mg film-coated tablet and one tenofovir disoproxil 245 mg film-coated tablet was established following single dose administration to fed, healthy subjects.
Danish: Bioækvivalensen mellem én Eviplera filmovertrukken tablet og en emtricitabin 200 mg hård kapsel, en rilpivirin (som hydrochlorid) 25 mg filovertrukket tablet og en tenofovirdisoproxil 245 mg filmovertrukken tablet blev fastlagt efter indgivelse af en enkelt dosis hos ikke-fastende, raske forsøgspersoner.
English: In a study of healthy subjects, supratherapeutic doses of rilpivirine (75 mg once daily and 300 mg once daily) have been shown to prolong the QTc interval of the ECG (see section 5.1).
Danish: I et studie med raske personer har supraterapeutiske doser af rilpivirin (75 mg én gang dagligt og 300 mg én gang dagligt) vist sig at forlænge QTc-intervallet på EKG'et (se pkt.
English: • If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Danish: • Kontakt Deres læge før De tager dette lægemiddel, hvis lægen har fortalt Dem, at De ikke tåler visse sukkerarter.
English: In this analysis, the NNRTI resistance-associated mutations that developed most commonly in these patients were: V90I, K101E, E138K/Q, V179I, Y181C, V189I, H221Y and F227C.
Danish: I denne analyse var de NNRTIresistensassocierede mutationer, der hyppigst blev udviklet hos disse patienter: V90I, K101E, E138K/Q, V179I, Y181C, V189I, H221Y og F227C.
English: The following pack sizes are available: outer cartons containing 1 bottle of 30 film-coated tablets and outer cartons containing 90 (3 bottles of 30) film-coated tablets.
Danish: Fås i pakninger, der indeholder 1 tabletbeholder med 30 filmovertrukne tabletter og pakninger indeholdende 90 (3 tabletbeholdere med 30) filmovertrukne tabletter.
English: • bone problems
Danish: • knogleproblemer
English: Elderly patients are more likely to have decreased renal function, therefore caution should be exercised when treating elderly patients with Eviplera (see section 4.4).
Danish: Da det er mere sandsynligt, at ældre patienter har nedsat nyrefunktion, skal der udvises forsigtighed ved behandling af ældre patienter med Eviplera (se pkt.
English: In women receiving rilpivirine 25 mg once daily during the 2nd trimester of pregnancy, mean intraindividual values for total rilpivirine Cmax, AUC24h and Cmin values were 21%, 29% and 35% lower, respectively, as compared to postpartum; during the 3rd trimester of pregnancy, Cmax, AUC24h and Cmin values were 20%, 31% and 42% lower, respectively, as compared to postpartum.
Danish: Hos kvinder, der fik rilpivirin 25 mg én gang dagligt i 2. trimester af graviditeten, var de intraindividuelle gennemsnitlige Cmax, AUC24h og Cmin værdier for total rilpivirin henholdsvis 21 %, 29 % og 35 % lavere sammenlignet med postpartum.
English: The K65R mutation can also be selected by abacavir or didanosine and results in reduced susceptibility to these agents plus to lamivudine, emtricitabine, and tenofovir.
Danish: K65R-mutationen kan desuden selekteres af abacavir eller didanosin og resultere i nedsat følsomhed for disse stoffer samt for lamivudin, emtricitabin og tenofovir.
English: Discontinued study drug due to AE or deathd
Danish: Seponering af studielægemidlet pga. bivirkninger eller dødd
English: HIV-1 containing the K103N, Y181C, or rilpivirine-associated substitutions with resistance to NNRTIs were susceptible to tenofovir.
Danish: Hiv 1 indeholder K103N-, Y181C-mutationen eller rilpivirinassocierede substitutioner med resistens over for NNRTI'er var følsomme for tenofovir.
English: ANALGESICS Paracetamol/Emtricitabine
Danish: ANALGETIKA Paracetamol/Emtricitabin
English: Resistance testing and/or historical resistance data should guide the use of Eviplera (see section 5.1).
Danish: Resistenstest og/eller historiske resistensdata skal være vejledende for anvendelsen af Eviplera (se pkt.
English: Emtricitabine-resistant viruses with the M184V/I mutation were cross-resistant to lamivudine, but retained sensitivity to didanosine, stavudine, tenofovir, zalcitabine and zidovudine.
Danish: Emtricitabin-resistente virus med M184V/I-mutationen var krydsresistente over for lamivudin, men beholdt følsomhed for didanosin, stavudin, tenofovir, zalcitabin og zidovudin.
English: • Yellow skin or eyes, itching or pain in the abdomen (tummy) caused by inflammation of the liver
Danish: • Gul hud eller gule øjne, kløe eller mavesmerter på grund af betændelse i leveren
English: • Rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Danish: • Rilpivirin, en non-nukleosid revers transkriptasehæmmer (NNRTI).
English: Exacerbations of hepatitis after discontinuation of treatment In HIV infected patients co-infected with HBV, clinical and laboratory evidence of hepatitis have occurred after discontinuation of treatment (see section 4.4).
Danish: Hepatitis-eksacerbationer efter seponering af behandling Hos hiv-inficerede patienter, som samtidigt er inficeret med HBV, er der forekommet klinisk og laboratoriemæssig evidens for hepatitis efter seponering af behandlingen (se pkt.
English: Co-administration of Eviplera and didanosine is not recommended as it results in a 40-60% increase in systemic exposure to didanosine that may increase the risk of didanosine-related adverse reactions (see section 4.5).
Danish: Samtidig administration af Eviplera og didanosin anbefales ikke, da det resulterer i en stigning i systemisk eksponering for didanosin på 40-60 %, hvilket kan øge risikoen for didanosinrelaterede bivirkninger (se pkt.
English: c There were 17 new virologic failures between the week 48 primary analysis and week 96 (6 patients with baseline viral load ≤ 100,000 copies/mL and 11 patients with baseline viral load > 100,000 copies/mL).
Danish: c Der var 17 nye virologiske svigt mellem den primære analyse ved uge 48 og uge 96 (6 patienter med baseline virusbelastning ≤ 100.000 kopier/ml og 11 patienter med baseline virusbelastning > 100.000 kopier/ml).
English: In patients with advanced liver disease or cirrhosis, treatment discontinuation is not recommended since post-treatment exacerbation of hepatitis may lead to hepatic decompensation.
Danish: Behandlingen bør ikke seponeres hos patienter med fremskreden leversygdom eller levercirrose, da hepatitis-eksacerbationer efter behandlingen kan føre til hepatisk dekompensation.
English: A subgroup analysis of the virologic response (< 50 HIV-1 RNA copies/mL) at both 48 weeks and 96 weeks, and virologic failure by baseline viral load (pooled data from the two Phase III clinical studies, C209 and C215, for patients receiving the emtricitabine/tenofovir disoproxil background regimen) is presented in Table 5.
Danish: En undergruppeanalyse af virologisk respons (< 50 hiv 1-rna-kopier/ml) ved både uge 48 og uge 96 og virologisk svigt ved baseline virusbelastning (samlede data fra de to kliniske fase III-studier, C209 og C215, for patienter, der fik et baggrundsprogram med emtricitabin/tenofovirdisoproxil) er vist i Tabel 5.
English: osteomalacia (manifested as bone pain and infrequently contributing to fractures)3, 5, 8, myopathy3, 5 Renal and urinary disorders Uncommon:
Danish: osteomalaci (manifesteret som knoglesmerter og i sjældne tilfælde medvirkende årsag til frakturer)3, 5, 8, myopati3, 5
English: Therefore, in patients with mild renal impairment Eviplera should only be used if the potential benefits of treatment are considered to outweigh the potential risks (see sections 4.2 and 4.4).
Danish: Derfor bør Eviplera kun anvendes hos patienter med let nedsat nyrefunktion, hvis de mulige fordele ved behandlingen anses for at opveje mulige risici (se pkt.
English: The mean (%CV) emtricitabine drug exposure increased from 12 (25%) µg•h/mL in patients with normal renal function, to 20 (6%) µg•h/mL, 25 (23%) µg•h/mL and 34 (6%) µg•h/mL, in patients with mild, moderate and severe renal impairment, respectively.
Danish: Den gennemsnitlige (% variationskoefficient) emtricitabineksponering steg fra 12 (25 %) µg•t/ml hos patienter med normal nyrefunktion til 20 (6 %) µg•t/ml, 25 (23 %) µg•t/ml og 34 (6 %) µg•t/ml hos patienter med henholdsvis let, moderat og svært nedsat nyrefunktion.
English: NARCOTIC ANALGESICS Methadone/Emtricitabine
Danish: NARKOTISKE ANALGETIKA Methadon/Emtricitabin
English: Raltegravir (400 mg twice daily)/ Tenofovir disoproxil
Danish: Raltegravir (400 mg to gange dagligt)/ Tenofovirdisoproxil
English: Emtricitabine-resistant viruses with the M184V/I substitution were cross-resistant to lamivudine, but retained sensitivity to didanosine, stavudine, tenofovir, and zidovudine.
Danish: Emtricitabin-resistente vira med M184V/I-substitutionen var krydsresistente over for lamivudin, men bibeholdt følsomhed for didanosin, stavudin, tenofovir og zidovudin.
English: No dose adjustment of Eviplera is required in patients with mild or moderate hepatic impairment.
Danish: Ingen dosisjustering af Eviplera er nødvendig hos patienter med let nedsat eller moderat nedsat leverfunktion.
English: Severe skin reactions with systemic symptoms have been reported during post-marketing experience with Eviplera, including rashes accompanied by fever, blisters, conjunctivitis, angioedema, elevated liver function tests, and/or eosinophilia (see section 4.4).
Danish: Alvorlige hudreaktioner med systemiske symptomer er blevet rapporteret efter markedsføring af Eviplera, herunder udslæt ledsaget af feber, blærer, konjunktivitis, angioødem, forhøjede leverfunktionsprøver og/eller eosinofili (se pkt.
English: • Pain, stomach pain or discomfort, feeling bloated, dry mouth
Danish: • Smerter, mavesmerter eller mavebesvær, oppustethed, mundtørhed
English: ANTIDIABETICS Metformin/Emtricitabine
Danish: ANTIDIABETIKA Metformin/Emtricitabin
English: Eviplera should not be administered concomitantly with rilpivirine hydrochloride unless needed for dose adjustment with rifabutin (see section 4.2).
Danish: Eviplera bør ikke indgives samtidig med rilpivirinhydrochlorid, medmindre dosisjustering er nødvendig i forbindelse med samtidig administration af rifabutin (se pkt.
English: d There were 10 new virologic failures between the week 48 primary analysis and week 96 (3 patients with baseline viral load ≤ 100,000 copies/mL and 7 patients with baseline viral load > 100,000 copies/mL).
Danish: d Der var 10 nye virologiske svigt mellem den primære analyse ved uge 48 og uge 96 (3 patienter med baseline virusbelastning ≤ 100.000 kopier/ml og 7 patienter med baseline virusbelastning > 100.000 kopier/ml).
English: Therefore, in patients with mild renal impairment Eviplera should only be used if the potential benefits of treatment outweigh the potential risks (see sections 4.4 and 5.2).
Danish: Derfor bør Eviplera kun anvendes hos patienter med let nedsat nyrefunktion, hvis de mulige fordele ved behandlingen opvejer mulige risici (se pkt.
English: IMMUNOSUPPRESSANTS Tacrolimus/Tenofovir disoproxil/ Emtricitabine
Danish: IMMUNOSUPPRESIVA Tacrolimus/Tenofovirdisoproxil/Emtricitabin Tacrolimus:
English: The pharmacokinetics of emtricitabine has not been studied in patients with varying degrees of hepatic insufficiency.
Danish: Emtricitabins farmakokinetik er ikke blevet undersøgt hos patienter med forskellige grader af leverinsufficiens.
English: HMG CO-A REDUCTASE INHIBITORS Atorvastatin/Emtricitabine
Danish: HMG CO-A-REDUKTASEHÆMMERE Atorvastatin/Emtricitabin
English: Eviplera should be administered with caution to elderly patients (see sections 4.4 and 5.2).
Danish: Eviplera bør administreres med forsigtighed til ældre patienter (se pkt.
English: Didanosine The co-administration of Eviplera and didanosine is not recommended (see section 4.4 and Table 1).
Danish: Didanosin Samtidig administration af Eviplera og didanosin anbefales ikke (se pkt.
English: Virologic failurec
Danish: Virologisk svigtc
English: Sildenafil (50 mg single dose)/ Rilpivirine1
Danish: Sildenafil (50 mg enkeltdosis)/Rilpivirin1
English: Co-administration of Eviplera and didanosine is not recommended since exposure to didanosine is significantly increased following co-administration with tenofovir disoproxil, which may increase the risk of didanosine-related adverse reactions (see section 4.5).
Danish: Samtidig administration af Eviplera og didanosin frarådes, da eksponering for didanosin er signifikant forhøjet efter samtidig administration af tenofovirdisoproxil, hvilket kan øge risikoen for didanosinrelaterede bivirkninger (se pkt.
English: Eviplera contains lactose and sunset yellow aluminium lake (E110)
Danish: Eviplera indeholder lactose og Sunset yellow FCF aluminium lak (E110)
English: If a patient vomits within 4 hours of taking Eviplera another Eviplera tablet should be taken with food.
Danish: Hvis en patient kaster op inden for 4 timer efter at have taget Eviplera, skal der tages en ny Evipleratablet sammen med mad.
English: Eviplera must be taken with food (see section 5.2).
Danish: Eviplera skal tages sammen med mad (se pkt.
English: Very common: increased transaminases (AST and/or ALT)1, 2, 3 Common:
Danish: forhøjede aminotransferaser (ASAT og/eller ALAT)1, 2, 3
English: H2-antagonists should not be taken in a twice a day regimen.
Danish: H2-antagonister bør ikke tages i et program med indtagelse to gange dagligt.
English: Interaction not studied with Eviplera.
Danish: Interaktion er ikke undersøgt med Eviplera.
English: HIV/HBV or HCV co-infected patients
Danish: Procentdel af patienter med samtidig infektion med HBV/HCV
English: Eviplera 200 mg/25 mg/245 mg film-coated tablets emtricitabine/rilpivirine/tenofovir disoproxil
Danish: Eviplera 200 mg/25 mg/245 mg filmovertrukne tabletter emtricitabin/rilpivirin/tenofovirdisoproxil
English: When your supply of Eviplera starts to run low, get more from your doctor or pharmacist.
Danish: Når De snart ikke har mere af Eviplera, skal De bede om mere fra lægen eller på apoteket.
English: Rilpivirine hydrochloride has not been studied in patients with severe hepatic impairment (CPT Score C).
Danish: Rilpivirinhydrochlorid er ikke undersøgt hos patienter med svært nedsat leverfunktion (CPT score C).
English: In patients with BL VL1 > 100,000 copies/mL (n = 44)
Danish: Hos patienter med virusbelastning ved baseline > 100.000 kop ier/ml (n = 44)
English: The mean (%CV) tenofovir Cmax and AUC0-∞ values were 223 (34.8%) ng/mL and 2,050 (50.8%) ng•h/mL, respectively, in normal subjects compared with 289 (46.0%) ng/mL and 2,310 (43.5%) ng•h/mL in subjects with moderate hepatic impairment, and 305 (24.8%) ng/mL and 2,740 (44.0%) ng•h/mL in subjects with severe hepatic impairment.
Danish: Tenofovirs gennemsnitlige (% variationskoefficient) Cmax- og AUC0-∞-værdier var henholdsvis 223 (34,8 %) ng/ml og 2.050 (50,8 %) ng•t/ml hos probander med normal leverfunktion sammenlignet med 289 (46,0 %) ng/ml og 2.310 (43,5 %) ng•t/ml hos probander med moderat nedsat leverfunktion og 305 (24,8 %) ng/ml og 2.740 (44,0 %) ng•t/ml hos probander med svært nedsat leverfunktion.
English: • Tell your doctor if you have an allergy to sunset yellow aluminium lake (E110).
Danish: • Fortæl Deres læge, hvis De lider af allergi over for Sunset yellow FCF aluminium lak
English: Co-administration of Eviplera with medicinal products that inhibit CYP3A enzyme activity has been observed to increase rilpivirine plasma concentrations.
Danish: Det er blevet observeret, at samtidig administration af Eviplera og lægemidler, der hæmmer CYP3A enzymaktiviten kan forhøje plasmakoncentrationer af rilpivirin.
English: Co-administration of Eviplera and medicinal products that induce CYP3A has been observed to decrease the plasma concentrations of rilpivirine which could potentially lead to loss of therapeutic effect of Eviplera (see section 4.3).
Danish: Det er blevet observeret, at samtidig administration af Eviplera og lægemidler, der inducerer CYP3A, nedsætter plasmakoncentrationer af rilpivirin, hvilket kunne medføre tab af den terapeutiske virkning af Eviplera (se pkt.
English: Antimycobacterials Rifabutin/Emtricitabine
Danish: Antimykobakterielle midler Rifabutin/Emtricitabin
English:  If you think you may have lactic acidosis, tell your doctor immediately.
Danish:  Hvis De tror, De har laktatacidose, skal De straks fortælle det til lægen.
English: Antiretrovirals
Danish: Antiretrovirale lægemidler
English: Herpesvirus antiviral agents Famciclovir/Emtricitabine
Danish: Antivirale midler mod herpesvirus Famciclovir/Emtricitabin